About the Authors
- Lucy Mathot
-
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Elin Falk-Sörqvist
-
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Lotte Moens
-
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Marie Allen
-
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Tobias Sjöblom
-
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Mats Nilsson
-
* E-mail: mats.nilsson@scilifelab.se
Affiliations Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden, Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, Sweden
Competing Interests
The authors have read the journal's policy and have the following conflicts: MN holds stock in the company Olink Bioscience that holds the commercial rights to the MLGA technique. Olink holds the following patents EP 19 97 909, US 7 320 860, US 7,790,388, and US 7 883 849, including, in applicable cases, foreign counterparts as well as divisionals and continuations of the above mentioned patents that may be relevant for the technology. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MN TS. Performed the experiments: L. Mathot. Analyzed the data: L. Mathot EFS L. Moens MA TS MN. Wrote the paper: L. Mathot EFS L. Moens MA TS MN.